Skip to main content
68°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Angle Plc ADR
(OP:
ANPCY
)
0.9670
UNCHANGED
Last Price
Updated: 11:52 AM EDT, Jun 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Angle Plc ADR
< Previous
1
2
3
4
5
Next >
Angle PLC Announces Holding(s) in Company
March 09, 2023
Via
ACCESSWIRE
Angle PLC Announces Director/PDMR Shareholding
February 09, 2023
Via
ACCESSWIRE
Angle PLC Announces Appointment of Non-Executive Director
January 19, 2023
Via
ACCESSWIRE
Angle PLC Announces Holding(s) in Company
January 11, 2023
Via
ACCESSWIRE
Angle PLC Announces Holding(s) in Company
January 10, 2023
Via
ACCESSWIRE
Angle plc Announces Appointment of Non-Executive Director
January 05, 2023
Via
ACCESSWIRE
Angle plc Announces Business Update
January 05, 2023
Via
ACCESSWIRE
Angle PLC Announces Two Parsortix Posters Presented at SABCS
December 12, 2022
Via
ACCESSWIRE
Angle PLC Announces Issue of Equity
December 02, 2022
Via
ACCESSWIRE
Angle PLC Announces Multiple Downstream Analysis Techniques for CTCs
November 02, 2022
Via
ACCESSWIRE
Angle PLC Announces Parsortix Poster Presented at ISLB Meeting
October 24, 2022
Via
ACCESSWIRE
Angle PLC Announces Issue of Equity
October 21, 2022
Via
ACCESSWIRE
Angle PLC Announces Streamlining of Operations to Increase Cash Runway
October 18, 2022
Via
ACCESSWIRE
Angle PLC announces TR-1: Notification of major holdings
October 17, 2022
Via
ACCESSWIRE
Angle PLC Announces First Regional Distribution Agreement
October 12, 2022
Via
ACCESSWIRE
Angle PLC Announces Holding(s) in Company
September 30, 2022
Via
ACCESSWIRE
Angle PLC Announces Issue of Equity
September 30, 2022
Via
ACCESSWIRE
Angle PLC Announces Interim Results
September 29, 2022
Via
ACCESSWIRE
Angle PLC Announces Positive Headline Results From Ovarian Study
September 29, 2022
Via
ACCESSWIRE
Angle PLC announces Study using Parsortix in head and neck cancer
September 28, 2022
Via
ACCESSWIRE
Angle PLC Announces New Poster Presented at ASCP Meeting
September 13, 2022
Via
ACCESSWIRE
Angle PLC Announces Novel Assay; Predicts Malignancy in Pelvic Mass
September 12, 2022
Via
ACCESSWIRE
Angle PLC Announces Notice of Interim Results and Webcast
September 01, 2022
Via
ACCESSWIRE
Angle PLC Announces Issue of Equity
July 08, 2022
Exercise of Options and Total Voting Rights
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Result of 2022 Annual General Meeting
June 29, 2022
GUILDFORD, SURREY / ACCESSWIRE / June 29, 2022 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that at the Annual General Meeting of the Company held earlier today,...
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Spread of Breast Cancer Accelerates During Sleep
June 27, 2022
BREAKTHROUGH RESEARCH WITH PARSORTIX REVEALS SPREAD OF BREAST CANCER ACCELERATES DURING SLEEP
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Issue of Equity
June 23, 2022
Exercise of Options and Total Voting Rights
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Secured Contract From Pharma Services Customer
June 22, 2022
Additional contract for a new clinical trial
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Predicting Immunotherapy Response in SCLC
June 16, 2022
PARSORTIX SYSTEM DEMONSTRATES POTENTIAL IN PREDICTING IMMUNOTHERAPY RESPONSE IN SMALL CELL LUNG CANCER
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Potential Role of Invasive Cellular Protrusions
June 14, 2022
Prostate cancer cells may use invasive cellular protrusions to aid entry into the blood stream, a potential target in the metastatic process for novel therapy development
From
ANGLE plc
Via
AccessWire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
